EPS Bio Technology Corp. (TPEX:4183)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.25
+0.15 (0.93%)
Mar 6, 2026, 11:46 AM CST
-30.11%
Market Cap 386.75M
Revenue (ttm) 497.19M
Net Income (ttm) -14.24M
Shares Out 23.80M
EPS (ttm) -0.60
PE Ratio n/a
Forward PE n/a
Dividend 0.67 (4.12%)
Ex-Dividend Date Aug 28, 2025
Volume 6,048
Average Volume 8,132
Open 16.10
Previous Close 16.10
Day's Range 16.10 - 16.25
52-Week Range 15.65 - 23.40
Beta 0.19
RSI 49.68
Earnings Date Mar 11, 2026

About EPS Bio Technology

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2006
Employees 109
Stock Exchange Taipei Exchange
Ticker Symbol 4183
Full Company Profile

Financial Performance

In 2024, EPS Bio Technology's revenue was 451.08 million, a decrease of -4.06% compared to the previous year's 470.17 million. Earnings were 17.31 million, a decrease of -17.54%.

Financial Statements

News

There is no news available yet.